The efficacy of chimeric vaccines constructed with PEP-1 and Ii-Key linking to a hybrid epitope from heterologous viruses. [electronic resource]
Producer: 20160902Description: 377-82 p. digitalISSN:- 1095-8320
- Antigens, Differentiation, B-Lymphocyte -- immunology
- Cysteamine -- analogs & derivatives
- Epitopes -- chemistry
- HEK293 Cells
- Histocompatibility Antigens Class II -- immunology
- Humans
- Newcastle disease virus -- immunology
- Peptides -- immunology
- Vaccines, Synthetic -- chemistry
- Viral Vaccines -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.